Glucose Insulin Potassium With Intensive Insulin Therapy and (GIK2) Versus GIK Alone
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the effect of the glucose insulin potassium (GIK)
infusion associated with intensive insulin therapy compared to GIK alone and control group in
patients presenting to the ED with acute coronary syndrome.